PHA Copolymer 3HH Composition via Beta-Ketothiolase Inhibition

Solution Overview

Problem

Current PHA copolymers, such as P(3HB-co-3HH), lack sufficient flexibility for applications like films and soft packaging due to limited 3HH composition ratios, restricting their industrial use.

Innovation Solution

A transformed microorganism with inhibited β-ketothiolase enzyme activity is used to enhance the 3HH composition ratio in PHA copolymers, achieved by genetic modifications such as gene knockout or reduction in enzyme activity, allowing for higher production of PHA copolymers with improved flexibility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If the 3HV molar fraction in P(3HB-co-3HV) is increased to improve flexibility, then the flexibility should be improved, but in practice the flexibility is not sufficiently improved and the material remains limited to hard-type molded products

Engineering Contradiction:
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent changes the monomer composition parameter from P(3HB-co-3HV) to P(3HB-co-3HH) by introducing 3-hydroxyhexanoic acid (3HH) monomer units. This parameter change in copolymer composition achieves superior flexibility improvement compared to increasing 3HV content, enabling the material to be processed into films, sheets, and soft-type packaging containers while maintaining adequate mechanical properties

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses wild-type Aeromonas caviae as a model organism to establish the baseline production capability of P(3HB-co-3HH), then creates transformed strains by introducing specific genes (phaC1, phaC2, phaP1, phaP2) to optimize and scale up the production system while maintaining the desired copolymer composition and flexibility properties

Inventive Principle:
Principle #26Copying

2Ease of operation

If P(3HB-co-3HH) is produced using wild-type Aeromonas caviae with fatty acid as carbon source, then the copolymer with higher flexibility can be obtained, but the production efficiency and 3HH composition ratio are limited

Engineering Contradiction:
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The patent segments the metabolic pathway by introducing separate gene modules: phaC1 and phaC2 for PHA synthase activity, phaP1 and phaP2 for phosphotransacetylase activity. This segmentation allows independent optimization of each enzymatic step to maximize 3HH incorporation efficiency while maintaining flexibility

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The transformed Aeromonas caviae strain is designed to perform multiple functions simultaneously: it maintains the wild-type's ability to produce flexible P(3HB-co-3HH) while additionally achieving high 3HH composition ratios (10-30 mol%) through introduced genes, and can utilize various carbon sources including fatty acids and sugars for efficient production

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Adaptability or versatility

If the 3HH composition ratio in P(3HB-co-3HH) is increased to enhance flexibility for films and soft packaging, then the applicable range is expanded, but the production method complexity increases

Engineering Contradiction:
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The transformed Aeromonas caviae strain is engineered to autonomously produce high 3HH composition P(3HB-co-3HH) through its introduced genetic machinery. The strain self-regulates the metabolic pathway to achieve 10-30 mol% 3HH incorporation without requiring complex external control systems or multiple processing steps, simplifying the overall production method while expanding application range to films and soft packaging

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The modified microorganism produces PHA copolymers with increased 3HH composition ratios, enhancing their flexibility and expanding their applicability beyond hard-type molded products to include flexible materials like films and soft packaging.

Implementation Method 1

a method for producing a PHA copolymer containing 3HH monomer unit, comprising a step of culturing the transformed microorganism using a carbon source comprising oil(s) and fat(s) or fatty acid(s) and a step of recovering a PHA copolymer containing 3HH monomer unit

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentUS11453896B2Transformed microorganism for producing PHA copolymer comprising 3HH monomer unit at high composition rate and method for producing PHA using same
Publication Date: 2022.09.27

AI summary

The present application provides: a transformed microorganism for producing a PHA copolymer containing 3HH monomer unit at a higher composition ratio, specifically, a transformed microorganism comprising a PHA synthase gene capable of synthesizing a PHA copolymer containing 3HH monomer unit and a gene encoding a protein having (R)-specific enoyl-CoA hydratase activity, characterized in that, in the transformed microorganism, the expression of a gene encoding at least one β-ketothiolase enzyme having thiolysis activity for β-keto-(C6) acyl-CoA (i.e., β-ketohexanoyl-CoA) is inhibited, thereby losing or reducing the enzyme activity; and a method for producing a PHA copolymer containing 3HH monomer unit, comprising a step of culturing the transformed microorganism.